Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid Carriers

Perillyl alcohol (POH), a bioactive monoterpenoid derived from limonene, shows promise as an antitumor agent for brain tumor treatment. However, its limited oral bioavailability and inadequate brain distribution hinder its efficacy. To address these challenges, this study developed nanostructured li...

Full description

Bibliographic Details
Main Authors: Samila Horst Peczek, Ana Paula Santos Tartari, Isabella Camargo Zittlau, Camila Diedrich, Christiane Schineider Machado, Rubiana Mara Mainardes
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/16/8/1055
_version_ 1797583578367787008
author Samila Horst Peczek
Ana Paula Santos Tartari
Isabella Camargo Zittlau
Camila Diedrich
Christiane Schineider Machado
Rubiana Mara Mainardes
author_facet Samila Horst Peczek
Ana Paula Santos Tartari
Isabella Camargo Zittlau
Camila Diedrich
Christiane Schineider Machado
Rubiana Mara Mainardes
author_sort Samila Horst Peczek
collection DOAJ
description Perillyl alcohol (POH), a bioactive monoterpenoid derived from limonene, shows promise as an antitumor agent for brain tumor treatment. However, its limited oral bioavailability and inadequate brain distribution hinder its efficacy. To address these challenges, this study developed nanostructured lipid carriers (NLCs) loaded with POH to improve its brain biodistribution. The NLCs prepared using hot homogenization exhibited an average diameter of 287 nm and a spherical morphology with a polydispersity index of 0.143. High encapsulation efficiency of 99.68% was achieved. X-ray diffraction analyses confirmed the semicrystalline state of POH-loaded NLCs. In vitro release studies demonstrated a biphasic release profile. Stability studies in simulated gastric and intestinal fluids confirmed their ability to withstand pH variations and digestive enzymes. In vivo pharmacokinetic studies in rats revealed significantly enhanced oral bioavailability of POH when encapsulated in the NLCs. Biodistribution studies showed increased POH concentration in brain tissue with NLCs compared with free POH, which was distributed more in non-target tissues such as the liver, lungs, kidneys, and spleen. These findings underscore the potential of NLCs as effective delivery systems for enhancing oral bioavailability and brain biodistribution of POH, providing a potential therapeutic strategy for brain tumor treatment.
first_indexed 2024-03-10T23:39:50Z
format Article
id doaj.art-ae6489179e9f4550b007cbb93b4cc543
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-10T23:39:50Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-ae6489179e9f4550b007cbb93b4cc5432023-11-19T02:33:11ZengMDPI AGPharmaceuticals1424-82472023-07-01168105510.3390/ph16081055Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid CarriersSamila Horst Peczek0Ana Paula Santos Tartari1Isabella Camargo Zittlau2Camila Diedrich3Christiane Schineider Machado4Rubiana Mara Mainardes5Laboratory of Nanostructured Formulations, Universidade Estadual do Centro-Oeste, Alameda Élio Antonio Dalla Vecchia St., 838, Guarapuava 85040-167, PR, BrazilLaboratory of Nanostructured Formulations, Universidade Estadual do Centro-Oeste, Alameda Élio Antonio Dalla Vecchia St., 838, Guarapuava 85040-167, PR, BrazilLaboratory of Nanostructured Formulations, Universidade Estadual do Centro-Oeste, Alameda Élio Antonio Dalla Vecchia St., 838, Guarapuava 85040-167, PR, BrazilLaboratory of Nanostructured Formulations, Universidade Estadual do Centro-Oeste, Alameda Élio Antonio Dalla Vecchia St., 838, Guarapuava 85040-167, PR, BrazilLaboratory of Nanostructured Formulations, Universidade Estadual do Centro-Oeste, Alameda Élio Antonio Dalla Vecchia St., 838, Guarapuava 85040-167, PR, BrazilLaboratory of Nanostructured Formulations, Universidade Estadual do Centro-Oeste, Alameda Élio Antonio Dalla Vecchia St., 838, Guarapuava 85040-167, PR, BrazilPerillyl alcohol (POH), a bioactive monoterpenoid derived from limonene, shows promise as an antitumor agent for brain tumor treatment. However, its limited oral bioavailability and inadequate brain distribution hinder its efficacy. To address these challenges, this study developed nanostructured lipid carriers (NLCs) loaded with POH to improve its brain biodistribution. The NLCs prepared using hot homogenization exhibited an average diameter of 287 nm and a spherical morphology with a polydispersity index of 0.143. High encapsulation efficiency of 99.68% was achieved. X-ray diffraction analyses confirmed the semicrystalline state of POH-loaded NLCs. In vitro release studies demonstrated a biphasic release profile. Stability studies in simulated gastric and intestinal fluids confirmed their ability to withstand pH variations and digestive enzymes. In vivo pharmacokinetic studies in rats revealed significantly enhanced oral bioavailability of POH when encapsulated in the NLCs. Biodistribution studies showed increased POH concentration in brain tissue with NLCs compared with free POH, which was distributed more in non-target tissues such as the liver, lungs, kidneys, and spleen. These findings underscore the potential of NLCs as effective delivery systems for enhancing oral bioavailability and brain biodistribution of POH, providing a potential therapeutic strategy for brain tumor treatment.https://www.mdpi.com/1424-8247/16/8/1055lipid nanoparticlesperillyl acidpharmacokineticsbiodistribution
spellingShingle Samila Horst Peczek
Ana Paula Santos Tartari
Isabella Camargo Zittlau
Camila Diedrich
Christiane Schineider Machado
Rubiana Mara Mainardes
Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid Carriers
Pharmaceuticals
lipid nanoparticles
perillyl acid
pharmacokinetics
biodistribution
title Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid Carriers
title_full Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid Carriers
title_fullStr Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid Carriers
title_full_unstemmed Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid Carriers
title_short Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid Carriers
title_sort enhancing oral bioavailability and brain biodistribution of perillyl alcohol using nanostructured lipid carriers
topic lipid nanoparticles
perillyl acid
pharmacokinetics
biodistribution
url https://www.mdpi.com/1424-8247/16/8/1055
work_keys_str_mv AT samilahorstpeczek enhancingoralbioavailabilityandbrainbiodistributionofperillylalcoholusingnanostructuredlipidcarriers
AT anapaulasantostartari enhancingoralbioavailabilityandbrainbiodistributionofperillylalcoholusingnanostructuredlipidcarriers
AT isabellacamargozittlau enhancingoralbioavailabilityandbrainbiodistributionofperillylalcoholusingnanostructuredlipidcarriers
AT camiladiedrich enhancingoralbioavailabilityandbrainbiodistributionofperillylalcoholusingnanostructuredlipidcarriers
AT christianeschineidermachado enhancingoralbioavailabilityandbrainbiodistributionofperillylalcoholusingnanostructuredlipidcarriers
AT rubianamaramainardes enhancingoralbioavailabilityandbrainbiodistributionofperillylalcoholusingnanostructuredlipidcarriers